VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,345 | -29.3% | 7,115 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $133,406 | +94.1% | 7,115 | +49.3% | 0.00% | – |
| Q1 2023 | $68,726 | -25.5% | 4,766 | 0.0% | 0.00% | – |
| Q4 2022 | $92,222 | -41.6% | 4,766 | +3.3% | 0.00% | -100.0% |
| Q3 2022 | $158,000 | +251.1% | 4,612 | +58.0% | 0.00% | – |
| Q2 2022 | $45,000 | -32.8% | 2,919 | 0.0% | 0.00% | – |
| Q1 2022 | $67,000 | – | 2,919 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |